← Back to opportunities

Provision of Hypertension and Lipids Optimisation Project

NHS Norfolk & Waveney Integrated Care Board

Buyer Contact Info

Buyer Name: NHS Norfolk & Waveney Integrated Care Board

Buyer Address: County Hall, Martineau Ln, Norwich, UKH15, NR1 2DH, United Kingdom

Contact Email: david.bailey1@nhs.net

Status
cancelled
Procedure
open
Value
n/a
Published
24 Nov 2025, 10:54
Deadline
n/a
Contract Start
n/a
Contract End
n/a
Category
services
CPV
85323000 - Community health services
Region
n/a
Awarded To
n/a
Official Source
Open Find a Tender

Description

This is a notice to inform the market the procurement has been abandoned.<br/><br/>NHS Norfolk and Waveney Integrated Care Board sought to procure a Hypertension and Lipids Optimisation Project. The successful provider staff was expected to work with the ICB Cardiovascular disease team, the N&W Protect NoW team, and General Practice to improve clinical effectiveness through case finding and management of patients.<br/><br/>NHS Norfolk and Waveney Integrated Care Board sought to launch a large-scale CVD Prevention project using a Population Health Management approach to case finding and intervention. The project will focus on hypertension and lipid management, with patients being identified and subsequently risk-stratified using the ICB software.<br/><br/>The ABCDE program aims to improve the care of patients at risk of Cardiovascular events through case finding and improved management of high-risk individuals. This project is considered a system priority to see our population lead healthier, longer lives, whilst simultaneously reducing pressures on the health system through early detection and management.<br/><br/>The successful provider is was expected to supply and manage Clinical Prescribers who will liaise with the ICB Protect NoW team, General Practice, and patients. A personalised care approach will be used to support pharmacological and social prescribing for our patient cohort.<br/>Prescribers must be able to initiate relevant medicines.<br/>Prescribers must initiate medicines in line with N&W criteria.<br/><br/>Patients will be identified using the ICB’s population health management software (Eclipse). The ICB Protect NoW Team will contact patients via digital (and print, if necessary) mediums to inform them of their relative risks and changes they can make in their lifestyles and diets and to encourage medication adherence where necessary.<br/><br/>Patients identified as eligible for medication will be consented by Protect NoW and subsequently made available to the provider, and the prescribers are to systematically contact this patient cohort and seek to initiate and / or optimise treatment in line with ICB and national guidance.<br/><br/>The provider will be expected to liaise with the relevant Practice where required on necessary ongoing management and monitoring.

Linked Documents

No linked documents found for this notice.

Opportunity Context

Lots

Lot Description: This is a notice to inform the market the procurement has been abandoned.<br/><br/>NHS Norfolk and Waveney Integrated Care Board sought to procure a Hypertension and Lipids Optimisation Project. The successful provider staff will be expected to work with the ICB Cardiovascular disease team, the N&W Protect NoW team, and General Practice to improve clinical effectiveness through case finding and management of patients.<br/><br/>This was a 1 year contract with the option to extend for up to an additional 2 years. The 1 year contract value is a a maximum of £200,000. Any additional extensions are estimated to be £200,000 per annum a maximum contract value of £600,000 over the full 3 year contract period.<br/><br/>Service Description:<br/><br/>NHS Norfolk and Waveney Integrated Care Board sought to launch a large-scale CVD Prevention project using a Population Health Management approach to case finding and intervention. The project will focus on hypertension and lipid management, with patients being identified and subsequently risk-stratified using the ICB software.<br/><br/>The ABCDE program aims to improve the care of patients at risk of Cardiovascular events through case finding and improved management of high-risk individuals. This project is considered a system priority to see our population lead healthier, longer lives, whilst simultaneously reducing pressures on the health system through early detection and management.<br/><br/>The successful provider was expected to supply and manage Clinical Prescribers who will liaise with the ICB Protect NoW team, General Practice, and patients. A personalised care approach will be used to support pharmacological and social prescribing for our patient cohort.<br/>Prescribers must be able to initiate relevant medicines.<br/>Prescribers must initiate medicines in line with N&W criteria.<br/><br/>Patients will be identified using the ICB’s population health management software (Eclipse). The ICB Protect NoW Team will contact patients via digital (and print, if necessary) mediums to inform them of their relative risks and changes they can make in their lifestyles and diets and to encourage medication adherence where necessary.<br/><br/>Patients identified as eligible for medication will be consented by Protect NoW and subsequently made available to the provider, and the prescribers are to systematically contact this patient cohort and seek to initiate and / or optimise treatment in line with ICB and national guidance.<br/><br/>The provider will be expected to liaise with the relevant Practice where required on necessary ongoing management and monitoring.

Lot 1 Status: cancelled

Lot 1 Has Options: No

Lot 1 Award Criterion (quality): Quality and Innovation

Lot 1 Award Criterion (cost): value

Lot 1 Award Criterion (cost): Integration, Collaboration and Service Sustainability

Lot 1 Award Criterion (cost): Improving Access, Reducing Health Inequalities and Facilitating Choice

Lot 1 Award Criterion (cost): Social Value

Raw Notice JSON

Expand raw payload
{
  "awards": [
    {
      "id": "076354-2025-1",
      "relatedLots": [
        "1"
      ],
      "status": "unsuccessful",
      "statusDetails": "discontinued"
    }
  ],
  "buyer": {
    "id": "GB-FTS-77568",
    "name": "NHS Norfolk \u0026 Waveney Integrated Care Board"
  },
  "date": "2025-11-24T10:54:32Z",
  "description": "The Commissioners made a decision to abandon the current process as permitted within Document 1 \u2013 ITT Process Overview document.  The justification was that the Commissioners requirements have changed and with recent announcement regarding future Commissioning Landscape, the Commissioners are withdrawing this process and intend to go back to out to market with a new service offer including revised documentation.",
  "id": "076354-2025",
  "initiationType": "tender",
  "language": "en",
  "ocid": "ocds-h6vhtk-04ee91",
  "parties": [
    {
      "address": {
        "countryName": "United Kingdom",
        "locality": "Norwich",
        "postalCode": "NR1 2DH",
        "region": "UKH15",
        "streetAddress": "County Hall, Martineau Ln"
      },
      "contactPoint": {
        "email": "david.bailey1@nhs.net"
      },
      "details": {
        "buyerProfile": "https://www.improvinglivesnw.org.uk/about-us/our-nhs-integrated-care-board-icb/icb-contact/",
        "classifications": [
          {
            "description": "Body governed by public law",
            "id": "BODY_PUBLIC",
            "scheme": "TED_CA_TYPE"
          },
          {
            "description": "Health",
            "id": "07",
            "scheme": "COFOG"
          }
        ],
        "url": "https://www.improvinglivesnw.org.uk/about-us/our-nhs-integrated-care-board-icb/icb-contact/"
      },
      "id": "GB-FTS-77568",
      "identifier": {
        "legalName": "NHS Norfolk \u0026 Waveney Integrated Care Board"
      },
      "name": "NHS Norfolk \u0026 Waveney Integrated Care Board",
      "roles": [
        "buyer"
      ]
    },
    {
      "address": {
        "countryName": "United Kingdom",
        "locality": "London",
        "postalCode": "SE1 8UG",
        "streetAddress": "Wellington House, 133-135 Waterloo Rd"
      },
      "contactPoint": {
        "email": "england.commercialqueries@nhs.net"
      },
      "details": {
        "url": "https://www.england.nhs.uk/"
      },
      "id": "GB-FTS-130973",
      "identifier": {
        "legalName": "NHS England"
      },
      "name": "NHS England",
      "roles": [
        "reviewBody"
      ]
    }
  ],
  "tag": [
    "award",
    "contract"
  ],
  "tender": {
    "classification": {
      "description": "Health services",
      "id": "85100000",
      "scheme": "CPV"
    },
    "description": "This is a notice to inform the market the procurement has been abandoned.\u003cbr/\u003e\u003cbr/\u003eNHS Norfolk and Waveney Integrated Care Board sought to procure a Hypertension and Lipids Optimisation Project. The successful provider staff was expected to work with the ICB Cardiovascular disease team, the N\u0026W Protect NoW team, and General Practice to improve clinical effectiveness through case finding and management of patients.\u003cbr/\u003e\u003cbr/\u003eNHS Norfolk and Waveney Integrated Care Board sought to launch a large-scale CVD Prevention project using a Population Health Management approach to case finding and intervention. The project will focus on hypertension and lipid management, with patients being identified and subsequently risk-stratified using the ICB software.\u003cbr/\u003e\u003cbr/\u003eThe ABCDE program aims to improve the care of patients at risk of Cardiovascular events through case finding and improved management of high-risk individuals. This project is considered a system priority to see our population lead healthier, longer lives, whilst simultaneously reducing pressures on the health system through early detection and management.\u003cbr/\u003e\u003cbr/\u003eThe successful provider is was expected to supply and manage Clinical Prescribers who will liaise with the ICB Protect NoW team, General Practice, and patients. A personalised care approach will be used to support pharmacological and social prescribing for our patient cohort.\u003cbr/\u003ePrescribers must be able to initiate relevant medicines.\u003cbr/\u003ePrescribers must initiate medicines in line with N\u0026W criteria.\u003cbr/\u003e\u003cbr/\u003ePatients will be identified using the ICB\u2019s population health management software (Eclipse). The ICB Protect NoW Team will contact patients via digital (and print, if necessary) mediums to inform them of their relative risks and changes they can make in their lifestyles and diets and to encourage medication adherence where necessary.\u003cbr/\u003e\u003cbr/\u003ePatients identified as eligible for medication will be consented by Protect NoW and subsequently made available to the provider, and the prescribers are to systematically contact this patient cohort and seek to initiate and / or optimise treatment in line with ICB and national guidance.\u003cbr/\u003e\u003cbr/\u003eThe provider will be expected to liaise with the relevant Practice where required on necessary ongoing management and monitoring.",
    "id": "Nw2025-89",
    "items": [
      {
        "additionalClassifications": [
          {
            "description": "Community health services",
            "id": "85323000",
            "scheme": "CPV"
          },
          {
            "description": "Services provided by medical personnel",
            "id": "85141000",
            "scheme": "CPV"
          },
          {
            "description": "Miscellaneous health services",
            "id": "85140000",
            "scheme": "CPV"
          }
        ],
        "deliveryAddresses": [
          {
            "region": "UKH1"
          }
        ],
        "id": "1",
        "relatedLot": "1"
      }
    ],
    "legalBasis": {
      "id": "32014L0024",
      "scheme": "CELEX"
    },
    "lots": [
      {
        "awardCriteria": {
          "criteria": [
            {
              "description": "55",
              "name": "Quality and Innovation",
              "type": "quality"
            },
            {
              "description": "0",
              "name": "value",
              "type": "cost"
            },
            {
              "description": "23",
              "name": "Integration, Collaboration and Service Sustainability",
              "type": "cost"
            },
            {
              "description": "12",
              "name": "Improving Access, Reducing Health Inequalities and Facilitating Choice",
              "type": "cost"
            },
            {
              "description": "10",
              "name": "Social Value",
              "type": "cost"
            }
          ]
        },
        "description": "This is a notice to inform the market the procurement has been abandoned.\u003cbr/\u003e\u003cbr/\u003eNHS Norfolk and Waveney Integrated Care Board sought to procure a Hypertension and Lipids Optimisation Project. The successful provider staff will be expected to work with the ICB Cardiovascular disease team, the N\u0026W Protect NoW team, and General Practice to improve clinical effectiveness through case finding and management of patients.\u003cbr/\u003e\u003cbr/\u003eThis was a 1 year contract with the option to extend for up to an additional 2 years. The 1 year contract value is a a maximum of \u00a3200,000. Any additional extensions are estimated to be \u00a3200,000 per annum a maximum contract value of \u00a3600,000 over the full 3 year contract period.\u003cbr/\u003e\u003cbr/\u003eService Description:\u003cbr/\u003e\u003cbr/\u003eNHS Norfolk and Waveney Integrated Care Board sought to launch a large-scale CVD Prevention project using a Population Health Management approach to case finding and intervention. The project will focus on hypertension and lipid management, with patients being identified and subsequently risk-stratified using the ICB software.\u003cbr/\u003e\u003cbr/\u003eThe ABCDE program aims to improve the care of patients at risk of Cardiovascular events through case finding and improved management of high-risk individuals. This project is considered a system priority to see our population lead healthier, longer lives, whilst simultaneously reducing pressures on the health system through early detection and management.\u003cbr/\u003e\u003cbr/\u003eThe successful provider was expected to supply and manage Clinical Prescribers who will liaise with the ICB Protect NoW team, General Practice, and patients. A personalised care approach will be used to support pharmacological and social prescribing for our patient cohort.\u003cbr/\u003ePrescribers must be able to initiate relevant medicines.\u003cbr/\u003ePrescribers must initiate medicines in line with N\u0026W criteria.\u003cbr/\u003e\u003cbr/\u003ePatients will be identified using the ICB\u2019s population health management software (Eclipse). The ICB Protect NoW Team will contact patients via digital (and print, if necessary) mediums to inform them of their relative risks and changes they can make in their lifestyles and diets and to encourage medication adherence where necessary.\u003cbr/\u003e\u003cbr/\u003ePatients identified as eligible for medication will be consented by Protect NoW and subsequently made available to the provider, and the prescribers are to systematically contact this patient cohort and seek to initiate and / or optimise treatment in line with ICB and national guidance.\u003cbr/\u003e\u003cbr/\u003eThe provider will be expected to liaise with the relevant Practice where required on necessary ongoing management and monitoring.",
        "hasOptions": false,
        "id": "1",
        "status": "cancelled"
      }
    ],
    "mainProcurementCategory": "services",
    "procurementMethod": "open",
    "procurementMethodDetails": "Open procedure",
    "status": "cancelled",
    "title": "Provision of Hypertension and Lipids Optimisation Project"
  }
}